Trade Summary

1 week ago, Broadwood Partners, L.P., serving as 10% owner at Insight Molecular Diagnostics Inc. (IMDX), purchased 570,184 shares at $3.56 per share, for a total transaction value of $2,032,251.00. Following this transaction, Broadwood Partners, L.P. now holds 25,369,925 shares of IMDX.

This purchase represents a 2.00% increase in Broadwood Partners, L.P.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, April 23, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 27, 2026, 4 days after the trade was made.

Insight Molecular Diagnostics Inc. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.